title: Management of the behavioral aspects of Parkinson's disease.
abstract: Parkinson's disease is a progressive and debilitating movement disorder that is diagnosed by its motor signs. The behavioral manifestations of Parkinson's disease are prevalent and frequently complicate the course of the disease. These may be due to the illness itself or its treatment and are often more disabling than the motor symptoms. This review focuses on the management of the most common behavioral symptoms of Parkinson's disease, including depression, anxiety, psychosis, dementia, delirium, sleep disorders, fatigue, apathy, emotionalism and compulsive behaviors.
authors.affiliation: Neurohealth Alzheimer's Disease and Movement Disorders Center, and Department of Geriatric Psychiatry, Butler Hospital, Warren Alpert Medical School of Brown University, RI, USA. leolisa@yahoo.com
authors.forename: Leora L
authors.initials: LL
authors.lastname: Borek
authors.forename: Kelvin L
authors.initials: KL
authors.lastname: Chou
authors.forename: Joseph H
authors.initials: JH
authors.lastname: Friedman
mesh_terms: D000928:Antidepressive Agents / Q000008:administration & dosage*; D000978:Antiparkinson Agents / Q000008:administration & dosage*; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D018697:Nootropic Agents / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D004338:Drug Combinations; D018697:Nootropic Agents